Anhui Palo Alto Pharmaceuticals, Inc.
Clinical trials sponsored by Anhui Palo Alto Pharmaceuticals, Inc., explained in plain language.
-
New inhaler aims to help control asthma breathing
Disease control Recruiting nowThis study is testing a new inhaled steroid medication called PA9159 for adults with asthma. It will compare the new inhaler to a commonly used steroid inhaler to see if it is safe and helps improve breathing. About 30 participants will use one of the inhalers for 4 weeks while r…
Phase: PHASE2 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New inhaler aims to help adults breathe easier
Disease control Recruiting nowThis study is testing a new inhaled steroid medication called PA9159 to see if it is safe and effective for controlling asthma in adults. About 60 participants with asthma will use either the new inhaler at different doses or a placebo inhaler for 4 weeks. Researchers will measur…
Phase: PHASE2 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC